Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 1,480 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Commercially Available Clear all

Conditions: COVID-19
Interventions: MP0420, Placebo, Remdesivir; Drug · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 485 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 73
States / cities: Tucson, Arizona • Chula Vista, California • Fresno, California + 52 more

Conditions: Cataract, Glaucoma, Ocular Hypertension
Interventions: Bimatoprost Implant System, SpyGlass IOL, Timolol Maleate Ophthalmic Solution, 0.5%, Commercial IOL; Drug · Device
Lead sponsor: SpyGlass Pharma, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hemorrhage, Pelvic Fracture
Interventions: Pelvic Binder; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Diabetic Foot Ulcer, Osteomyelitis Chronic
Interventions: Borate-base Bioactive Glass Fiber Matrix (BBGFM); Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Liver Neoplasms
Interventions: SonoVue®; Drug
Lead sponsor: Bracco Diagnostics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 353 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Obese Patients, Tobacco Use, Veterans, Family History of Esophageal Cancer, Barrett Esophagus
Interventions: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy.; Diagnostic Test
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 40 Years to 85 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Systemic Lupus Erythematosus (Sle)
Interventions: Nicotinamide Riboside; Dietary Supplement
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes
Interventions: BD Scarlett Infusion set, Medtronic QuickSet Infusion Set; Device
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Sensorineural Hearing Loss
Interventions: Experimental sound coding strategy (FAST), Commercially available ACE sound coding strategy; Device
Lead sponsor: Cochlear; Industry
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Osteoporosis
Interventions: teriparatide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 18
States / cities: Huntsville, Alabama • Montgomery, Alabama • Peoria, Arizona + 15 more

Conditions: Covid-19, Cognitive Impairment
Interventions: Speed of Processing Training, Instrumental Activities of Daily Living Shaping, Transfer Package from CI Therapy, Usual Care; Behavioral · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Sensory Information Processing Training, Active Control Training; Behavioral
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Diabetes Mellitus
Interventions: Phase 1- Introduction to Dexcom G6 CGM; Device
Lead sponsor: DexCom, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Henderson, Nevada

Conditions: Cancer
Interventions: Rosuvastatin10 mg tablet, Midazolam 3 mg syrup, Dabrafenib 75 mg capsule; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Aortic Stenosis Treated With TAVI, Aortic Diseases
Interventions: F2 Filter and Delivery System, Transcatheter Aortic Valve Replacement (TAVR); Device · Procedure
Lead sponsor: EnCompass Technologies, Inc.; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Naples, Florida • Indianappolis, Indiana • Detroit, Michigan + 5 more

Conditions: Unilateral Spatial Neglect, Stroke
Interventions: Prism adaptation training combined with TENS, PAT only; Device · Other
Lead sponsor: Kettering Health Network; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Centerville, Ohio

Conditions: Vitamin D Deficiency, Metabolic Syndrome, Prediabetes
Interventions: Mushroom with 600 IU vitamin D2, Mushroom with 4000 IU Vitamin D2, 600 IU Vitamin D3 and untreated mushroom, 4000 IU Vitamin D3 and untreated mushroom, Placebo; Dietary Supplement · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 30 Years to 90 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Wrinkle
Interventions: Almond; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Breast Cancer
Interventions: Tamoxifen, Lumpectomy, brachytherapy; Drug · Procedure · Radiation
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 18 Years and older · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Bloating, Bowel Irregularities, Bowel Gas
Interventions: Fiber supplement; Dietary Supplement
Lead sponsor: Bell Cinical Service; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Edina, Minnesota

Conditions: Presbyopia
Interventions: Multifocal soft contact lenses, Progressive addition lens spectacles; Device · Other
Lead sponsor: Alcon Research; Industry
Eligibility: 38 Years to 58 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: m-health cardiac rehabilitation; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Left Ventricular Assist Device, Percutaneous Lead Management
Interventions: Percutaneous Lead Management Kit; Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 16 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 5
States / cities: Birmingham, Alabama • San Diego, California • Ann Arbor, Michigan + 2 more

Conditions: Schizophrenia, Schizoaffective Disorder, Chronic Mental Disorder, Major Depression, Bipolar Disorder
Interventions: The Thinking Skills for Work Program, The Cognitive Skills for Work Program; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 2
States / cities: Chicago, Illinois • Manchester, New Hampshire

Search by objective public record fields.

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

Pre-hospital Advanced Therapies for Control of Hemorrhage - Pelvis

Mirragen Diabetic Foot Ulcer Study

SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization

Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults

Fundamental Asynchronous Stimulus Timing Sound Coding Study

Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy

Improving Thinking in Everyday Life After Covid-19

Perceptual Deficits in Schizophrenia

Assessing Non-adjunctive CGM Safety at Home and in New Markets

Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect

Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom

The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Fiber Product for Gas, Bloating, and Bowel Regularity

Multifocal Visual Performance Study

Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction

Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study

Understanding How Cognitive Remediation Works